At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients by delivering superior, long-term outcomes compared to current anti-cancer therapies. We are pioneers who rapidly translate discoveries into innovations and innovations into differentiated therapeutic solutions, to address the most significant unmet medical needs in oncology. We are based in Branford, CT and Farmington, CT.
EvolveImmune Therapeutics的外部链接
Explore our Career Opportunities at EvolveImmune!
Passionate about transforming cancer treatment? Join us! ?? EvolveImmune Therapeutics is pioneering next-gen precision medicines to redefine patient outcomes. Explore our Position for a Postdoctoral Fellow Scientist #EvolveImmune #BiotechCareers #ImmunoOncology #CancerResearch #Immunobiology
Would you like to be a part of our vibrant team? We’re hiring a Senior Research Associate in immunobiology at EvolveImmune Therapeutics. Join us in pioneering a new class of precision cancer medicines to deliver superior patient outcomes compared to current anti-cancer therapies. #careeropportunities #EvolveImmuneTherapeutics
Passionate about transforming cancer treatment? Join us! ?? EvolveImmune Therapeutics is pioneering next-gen precision medicines to redefine patient outcomes. Explore our career opportunities! #EvolveImmune #BiotechCareers #Immunobiology #CancerResearch #ResearchAssociate
As we mark the 10th?anniversary of International Day for Women & Girls in Science, we are excited to announce that?Kristen Hege?has joined our Board of Directors. Dr. Hege brings decades of experience?advancing novel cancer molecules from early stage through FDA approval to our Board. Her expertise in cancer immunotherapy will provide critical insights to us?as we prepare?to enter the clinic in mid-2025 with our lead molecule, EVOLVE104.?? #womeninscience #cancer #oncology #immunotherapy #TeamEvolveImmune
Excited to welcome Tony Fiorino as our new Senior Vice President of Clinical Development. Tony brings a wealth of early- and late-stage clinical development experience in oncology and immunology. Looking forward to beginning the clinical program our first-in-category EVOLVE104 asset under Tony’s leadership in 2025. #biotech #cancer #oncology #immunotherapy #TeamEvolveImmune
Delighted to showcase our most recent?#EVOLVE?advances at?#ASH24. Stop by to learn more about our differentiated approach to tackling therapeutic challenges in DLBCL and autoimmunity!? #ForPatients #CD2 #Xingyue (Amy) An
We are thrilled to announce our collaboration and option-to-license agreement with AbbVie to develop multispecific biologics for multiple targets in #oncology. The partnership will leverage our proprietary biotherapeutics platform for the treatment of malignancies with high unmet needs. Kudos to our team members for their dedication to pioneering science and steadfast commitment to patients! #ForPatients #EvolveImmune #Collaboration #Team https://lnkd.in/ej8X8hwt
We're #hiring a new Senior Manager, Program and Alliance Management in Branford, Connecticut. Apply today or share this post with your network.
We're #hiring a new Principal Scientist, Immunobiology in Branford, Connecticut. Apply today or share this post with your network.
Proud to have shared key advances for our EVOLVE104 and EVOLVE205 programs, driven by the power of integrated CD2 costimulation. #Teamwork #CD2 #EVOLVE #ForPatients https://lnkd.in/euYcDRgB